FI915089A7 - Uusia muramyylidipeptidijohdannaisia ja näitä johdannaisia sisältävä influenssarokote - Google Patents

Uusia muramyylidipeptidijohdannaisia ja näitä johdannaisia sisältävä influenssarokote Download PDF

Info

Publication number
FI915089A7
FI915089A7 FI915089A FI915089A FI915089A7 FI 915089 A7 FI915089 A7 FI 915089A7 FI 915089 A FI915089 A FI 915089A FI 915089 A FI915089 A FI 915089A FI 915089 A7 FI915089 A7 FI 915089A7
Authority
FI
Finland
Prior art keywords
derivatives
influenza vaccine
vaccine containing
muramyl dipeptide
novel muramyl
Prior art date
Application number
FI915089A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI915089A0 (fi
FI915089L (fi
Inventor
Masaharu Oki
Hideya Tsuge
Kunio Ohkuma
Tetsuya Oka
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI915089A0 publication Critical patent/FI915089A0/fi
Publication of FI915089L publication Critical patent/FI915089L/fi
Publication of FI915089A7 publication Critical patent/FI915089A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI915089A 1990-10-30 1991-10-29 Uusia muramyylidipeptidijohdannaisia ja näitä johdannaisia sisältävä influenssarokote FI915089A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29333690 1990-10-30
JP29333590 1990-10-30

Publications (3)

Publication Number Publication Date
FI915089A0 FI915089A0 (fi) 1991-10-29
FI915089L FI915089L (fi) 1992-05-01
FI915089A7 true FI915089A7 (fi) 1992-05-01

Family

ID=26559366

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915089A FI915089A7 (fi) 1990-10-30 1991-10-29 Uusia muramyylidipeptidijohdannaisia ja näitä johdannaisia sisältävä influenssarokote

Country Status (16)

Country Link
US (1) US5292506A (show.php)
EP (2) EP0680974A1 (show.php)
KR (1) KR920008064A (show.php)
CN (1) CN1062146A (show.php)
AU (1) AU642048B2 (show.php)
CA (1) CA2054228A1 (show.php)
FI (1) FI915089A7 (show.php)
HU (1) HUT62199A (show.php)
IE (1) IE913765A1 (show.php)
IL (1) IL99851A (show.php)
MX (1) MX9101820A (show.php)
NO (1) NO914233D0 (show.php)
NZ (1) NZ240369A (show.php)
PT (1) PT99389A (show.php)
RU (1) RU2074192C1 (show.php)
TW (1) TW207545B (show.php)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612037A (en) * 1994-07-26 1997-03-18 Connaught Laboratories, Inc. Influenza virus subunit conjugates
CN1253220C (zh) * 2001-06-29 2006-04-26 贝克顿迪肯森公司 通过微管在真皮内输入疫苗和基因治疗剂
US20040247661A1 (en) * 2002-07-03 2004-12-09 Dov Michaeli Liposomal vaccine
CN1665487A (zh) * 2002-07-03 2005-09-07 埃弗顿有限公司 脂质体疫苗
US20050169979A1 (en) * 2002-07-03 2005-08-04 Dov Michaeli Liposomal vaccine
US20050123550A1 (en) * 2003-05-12 2005-06-09 Laurent Philippe E. Molecules enhancing dermal delivery of influenza vaccines
US7588774B2 (en) * 2003-05-12 2009-09-15 Becton, Dickinson And Company Molecules enhancing dermal delivery of influenza vaccines
TWI329130B (en) 2003-06-19 2010-08-21 Bestewil Holding Bv Functionally reconstituted viral membranes containing adjuvant
BRPI0417225A (pt) * 2003-12-05 2007-03-06 Becton Dickinson Co métodos de aumentar a resposta imune no compartimento intradérmico e compostos úteis nos referidos métodos
RS51665B (sr) 2004-09-09 2011-10-31 Novartis Vaccines And Diagnostics Gmbh. Smanjenje potencijalnih jatrogenih rizika povezanih sa vakcinama protiv gripa
AU2005314563B2 (en) 2004-11-03 2011-06-30 Seqirus UK Limited Influenza vaccination
US20060121055A1 (en) * 2004-12-06 2006-06-08 Becton, Dickinson And Company, Inc. Compositions with enhanced immunogenicity
CN101100483B (zh) * 2006-07-07 2011-12-07 中国医学科学院药物研究所 胞壁酰二肽的类似物
WO2008024075A1 (en) 2006-08-25 2008-02-28 Agency For Science, Technology And Research Modulators of candida hyphal morphogenesis and uses thereof
WO2008112218A2 (en) 2007-03-12 2008-09-18 Antigen Express, Inc. Li-rnai involved li suppression in cancer immunotherapy
AU2011300402B2 (en) 2010-09-07 2015-01-22 Novartis Ag Generic assays for detection of mammalian reovirus
WO2013172517A1 (ko) 2012-05-16 2013-11-21 서울대학교산학협력단 뮤라밀-다이펩타이드를 포함하는 골소실 예방, 골재생 또는 골형성 촉진용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
US4895835A (en) * 1987-11-20 1990-01-23 Nisshin Oil Mills, Ltd. Muramyl peptide derivatives and use thereof
HU205147B (en) * 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same

Also Published As

Publication number Publication date
MX9101820A (es) 1992-06-05
AU642048B2 (en) 1993-10-07
KR920008064A (ko) 1992-05-27
RU2074192C1 (ru) 1997-02-27
HUT62199A (en) 1993-04-28
IL99851A (en) 1996-06-18
EP0487909A3 (en) 1992-08-12
FI915089A0 (fi) 1991-10-29
HU913398D0 (en) 1992-01-28
CA2054228A1 (en) 1992-05-01
US5292506A (en) 1994-03-08
TW207545B (show.php) 1993-06-11
IE913765A1 (en) 1992-05-22
PT99389A (pt) 1992-09-30
FI915089L (fi) 1992-05-01
NO914233D0 (no) 1991-10-29
NZ240369A (en) 1993-09-27
AU8684991A (en) 1992-05-07
CN1062146A (zh) 1992-06-24
EP0487909A2 (en) 1992-06-03
IL99851A0 (en) 1992-08-18
EP0680974A1 (en) 1995-11-08

Similar Documents

Publication Publication Date Title
KR900011476A (ko) 백신 제제
DK272889D0 (da) Vaccine
ATE188613T1 (de) Adjuvantien enthaltende impfstoffzusammensetzung
DE69126606D1 (de) Vakzine
FI931169A7 (fi) Parannetut rokotekoostumukset
FI943171L (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
CY2007016I2 (el) Εμβολιο ιου θηλωματος
NO930699D0 (no) Hoeyeffektiv vaeske/vaeske hydrosyklon
DE69027112D1 (de) Impfstoffzusammensetzung
FI944052A0 (fi) Oraalinen rokote
DK189788D0 (da) Vaccine
IL99851A0 (en) Muramyldipeptide derivatives and influenza vaccine containing them
FI944906A0 (fi) Uudet sykliset aminohapot ja niiden johdannaiset
KR930702527A (ko) gp160의 유도체 및 보조약을 함유하는 gp160 또는 그의 유도체를 기재로하는 백신
FI903232A7 (fi) Muramyylidipeptidijohdannaisia
FI925032L (fi) Vaccinsammansaettningar
ATE134386T1 (de) Vakzin-zusammensetzung
FI934866A7 (fi) Liposomaaliset polysakkaridirokotteet
FI912884A7 (fi) Gemfibrotsiilivalmiste ja menetelmä sen valmistamiseksi
NO943251D0 (no) Oral vaksine
BR9007246A (pt) Preparacao de vacinas
NO923242D0 (no) Oral vaksine
ZA918588B (en) Novel muramyldipeptide derivatives and influenza vaccine comprising the derivatives
FI885120A7 (fi) Penikkataudin viruksen vastainen rokote
ID1028B (id) Vaksin

Legal Events

Date Code Title Description
FD Application lapsed